NIH-funded research U01 cooperative agreement

Network coordinating care and work on chronic pancreatitis, pancreatitis-related diabetes, and pancreatic cancer

Official title: Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC)

Funded at University of Tx Md Anderson Can Ctr · NIH-11212226 · Data updated 2026-11-12

This program brings together hospitals to collect medical information and samples from people with chronic pancreatitis, pancreatitis-related diabetes, and pancreatic cancer to speed better tests and treatments.

More Pancreatitis research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startSeptember 28, 2015
Project endJune 30, 2030
Funding year2025
Award (this year)$1,583,252
NIH project number2U01DK108328-11
Project IDNIH-11212226 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people seen at participating sites with chronic or recurrent pancreatitis, pancreatitis-related (pancreatogenic) diabetes, or a diagnosis or high risk of pancreatic cancer who can attend follow-up at a consortium clinic.

Less likely to help

People without pancreatic disease, those seeking an immediate new therapy, or those unable to visit participating centers are unlikely to benefit directly from this coordination-focused program.

What this research studies

This coordinating center runs a national network that enrolls people with chronic or recurrent pancreatitis, pancreatitis-related diabetes, and pancreatic cancer at multiple medical centers. Participants have clinic visits, medical record reviews, imaging and lab tests, and may donate blood or tissue samples to a shared biobank. The center organizes data collection, quality control, and links clinical information with biospecimens so researchers can look for patterns, biomarkers, and treatment targets over time. It supports multicenter efforts (for example PROCEED, INSPPIRE2, NOD, and DETECT) to make findings comparable across hospitals and speed discoveries.

Why it matters

Potential benefit: If successful, this work could lead to earlier diagnosis, better biomarker tests, and more effective treatments for pancreatitis-related complications, pancreatogenic diabetes, and pancreatic cancer.

How similar studies have gone: Earlier CPCRC multicenter efforts such as PROCEED and INSPPIRE2 have successfully collected long-term data and biospecimens and yielded new insights, although new treatments remain limited and more work is needed.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Li, Liang — University of Tx Md Anderson Can Ctr
  • Study coordinator: Li, Liang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.